Broad Institute holds its ground in CRISPR IP dispute

The question of who first invented CRISPR gene editing technology should finally be answered late next year, and the latest development in the IP battle suggests the Broad Institute holds the dominant position leading into the next phase of the fight. 

On Thursday, the U.S. Patent and Trial Appeal Board (PTAB) released its decision on motions in the second major interference case involving CRISPR patents filed by the Broad Institute of MIT and Harvard and a University of California group, the two parties vying for foundational IP rights. ...